Position in NBIX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,012,948
-$161,120 QoQ
Shares Held
7,689
-7.1% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026QUADRANT CAPITAL GROUP LLC holds $18,364,187 across 30 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
489,799 | $6,783,716 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
127,505 | $2,361,392 | |
| 3 | ZTS |
Zoetis Inc.
|
17,457 | $2,063,591 | |
| 4 | HLN |
Haleon plc
|
118,327 | $1,184,453 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
7,689 | $1,012,948 | |
| 6 | VTRS |
Viatris Inc
|
70,339 | $950,279 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
24,340 | $733,120 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
7,890 | $598,456 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,012,948 | 7,689 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,174,068 | 8,278 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,159,258 | 8,258 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $958,009 | 7,622 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $882,698 | 7,981 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $312,448 | 2,289 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $266,388 | 2,312 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $324,625 | 2,358 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $290,459 | 2,106 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $273,402 | 2,075 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $224,662 | 1,997 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $116,177 | 1,232 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $83,708 | 827 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $155,869 | 1,305 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $99,624 | 938 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $32,850 | 337 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $37,031 | 395 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $511 | 6 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $18,222 | 190 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,741 | 59 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $10,308 | 106 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $7,955 | 83 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $28,655 | 298 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $89,914 | 737 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $61,015 | 705 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||